跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Andros - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Andros
Approved
STANDARD
Andros
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d3eaec2f4ac6c979
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
d3eaec2f4ac6c979
Drug Approval Philippines Name
Andros
Product Name
Andros
Registration Number
DRP-3051
Brand Name
Andros
Generic Name
Sildenafil Citrate
Dosage Form
Film-Coated Tablet
Dosage Strength
100 mg
Manufacturer
Amherst Laboratories, Inc.
Distributor
United Laboratories, Inc.
Issuance Date
27 July 2022
Expiry Date
05 November 2027
Pharmacologic Category
Urological (Drug Used in Erectile Dysfunction)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d3eaec2f4ac6c979
Type
Standard
Back to Philippines FDA Approvals